Bendroflumethiazide 5mg tablets

Ország: Egyesült Királyság

Nyelv: angol

Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktív összetevők:

Bendroflumethiazide

Beszerezhető a:

RX Farma

ATC-kód:

C03AA01

INN (nemzetközi neve):

Bendroflumethiazide

Adagolás:

5mg

Gyógyszerészeti forma:

Oral tablet

Az alkalmazás módja:

Oral

Osztály:

No Controlled Drug Status

Recept típusa:

Valid as a prescribable product

Termék összefoglaló:

BNF: 02020100; GTIN: 5060637640210

Betegtájékoztató

Continued, please turn over
SPECIAL
TRIM
Package leaflet: Information for the Patient
BENDROFLUMETHIAZIDE 2.5MG TABLETS
BENDROFLUMETHIAZIDE 5MG TABLETS
(BENDROFLUMETHIAZIDE)
This medicine will be called Bendroflumethiazide
Tablets in this leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor,
pharmacist or nurse.
•
This medicine is only for you. Do not pass it to others. It may
harm them, even if their signs of illness are the same as yours.
•
If you get any of the side effects, talk to your doctor,
pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Bendroflumethiazide Tablets is and what it is used for
2.
What you need to know before you take
Bendroflumethiazide Tablets
3.
How to take Bendroflumethiazide Tablets
4.
Possible side effects
5.
How to store Bendroflumethiazide Tablets
6.
Contents of the pack and other information
1. What Bendroflumethiazide Tablets
is and what it is used for
These tablets are available in two different strengths, 2.5mg and
5mg and your doctor will have decided which is the most
suitable for you.
Bendroflumethiazide belongs to a group of medicines called
diuretics (water tablets) which increase urine production.
Bendroflumethiazide Tablets are used to treat hypertension (high
blood pressure) and oedema (fluid retention) associated with
such conditions as kidney disorder, liver damage, heart failure
and premenstrual fluid retention.
2. What you need to know before you
take Bendroflumethiazide Tablets
DO NOT TAKE BENDROFLUMETHIAZIDE TABLETS:
•
If you ever had an allergic reaction to bendroflumethiazide or
any other ingredients of this medicine (allergic reactions
include mild symptoms such as itching and/or rash. More
severe symptoms include swelling of the face, lips, tongue
and/or throat with difficulty in swa

Termékjellemzők

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Bendroflumethiazide 5mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Bendroflumethiazide 5mg.
For a full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablets for oral use.
White, circular flat faced tablets with bevelled edges, B 5 separated
by a
break line on one face and plain on the reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Bendroflumethiazide is a diuretic. The tablets are indicated for the
treatment of
essential hypertension and oedema associated with such conditions as
nephrotic syndrome, cirrhosis of the liver, congestive heart failure
and pre-
menstrual oedema.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Adults: _
Oedema
5-10mg daily in the morning initially.
Maintenance: usually 2.5mg-5mg on only two or
three days in the week. A single dose may be
sufficient
Essential Hypertension
2.5mg in the morning. Doses above 2.5mg are
rarely necessary.
Pre-menstrual syndrome
2.5mg each morning for seven days before the
period is due.
_ _
_Children:_
Oedema Up to 400 micrograms per kg body weight daily
initially, reducing to 50-100 micrograms per kg
for maintenance.
Elderly:
The dosage of thiazide diuretics may need to be reduced in the
elderly,
particularly when renal function is impaired, because of the
possibility of
electrolyte imbalance.”
4.3
CONTRAINDICATIONS
Bendroflumethiazide tablets are contraindicated in patients with known
hypersensitivity to thiazides; hypercalcaemia, hyponatraemia,
refractory
hypokalemia, severe renal and hepatic insufficiency, symptomatic
hyperuricaemia and Addison's disease.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
HYPOKALAEMIA
Electrolytes should be monitored during treatment as continued or
intensive use of
bendroflumethiazide may result in hypokalaemia. This effect may be
enhanced with
concomitant use of medicines that can also cause hypokalaemia such as
other
diuretics or beta-2 agonists. Hypokalaemia can increase the risk of
cardiac arrhythmia
partic